The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages 397-402

  Zairis, Michael N ^a   Adamopoulou, Evdokia N ^a   Manousakis, Stavros J ^a   Lyras, Anastassios G ^a   Bibis, George P ^a   Ampartzidou, Olga S ^a   Apostolatos, Charalambos S ^a   Anastassiadis, Filippos A ^a   Hatzisavvas, John J ^a   Argyrakis, Spyros K ^a   Foussas, Stefanos G ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Acute coronary syndromes; Inflammatory biomarkers; Prognosis; Risk stratification

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENOXAPARIN; FIBRINOGEN; HEPARIN; INTERLEUKIN 6; SERUM AMYLOID A; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG DOSE TITRATION; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; ST SEGMENT ELEVATION;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOGEN; GREECE; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SERUM AMYLOID A PROTEIN;

EID: 34848883881     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.008     Document Type: Article

References (25)

1. Ross R. Atherosclerosis-an inflammatory disease. New Engl J Med 340 (1999) 115-126
2. Pietilä K.O., Harmoinen A.P., Jokiniitty J., and Pasternack A.I. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 17 (1996) 1345-1349
3. Nikfardjam M., Mullner M., Schreiber W., et al. The association between C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 247 (2000) 341-345
4. Suleiman M., Aronson D., Reisner S.A., et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 115 (2003) 695-701
5. Zairis M.N., Manousakis S.J., Stefanidis A.S., et al. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J 144 (2002) 782-789
6. Foussas S.G., Zairis M.N., Lyras A.G., et al. Early prognostic usefulness of C-reactive protein added to the thrombolysis in myocardial infarction risk score in acute coronary syndromes. Am J Cardiol 96 (2005) 533-537
7. Horne B.D., Muhlestein J.B., Carlquist J.F., et al. Statin therapy, lipid levels. C-reactive protein and the survival of patients with angiographically severe coronary artery disease. J Am Coll Cardiol 37 (2001) 2010-2011
8. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. New Engl J Med 343 (2000) 1139-1147
9. Mueller C., Buettner H.J., Hodgson J.M., et al. Inflammation and long-term mortality after non-ST-elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 105 (2002) 1412-1415
10. Toss H., Lindahl B., Siegbahn A., and Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in coronary artery disease. Circulation 96 (1997) 4204-4210
11. Zebrack J.S., Anderson J.L., Beddhu S., et al. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?. J Am Coll Cardiol 42 (2003) 57-63
12. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. New Engl J Med 331 (1994) 417-424
13. Morrow D.A., Rifai N., Antman E.M., et al. Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 35 (2000) 358-362
14. Bodi V., Sanchis J., Llacer A., et al. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. Am Heart J 149 (2005) 268-274
15. Lindmark E., Diderholm E., Wallentin L., and Siegbahn A. Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or non-invasive strategy. JAMA 286 (2001) 2107-2113
16. Yen M.H., Bhatt D.L., Chew D.P., et al. Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. Am J Med 115 (2003) 318-321
17. Sabatine M.S., Morrow D.A., Cannon C.P., et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 40 (2002) 1761-1768
18. Barron H.V., Harr S.D., Radford M.J., Wang Y., and Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 38 (2001) 1654-1661
19. Barron H.V., Cannon C.P., Murphy S.A., Braunwald E., and Gibson C.M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 102 (2000) 2329-2334
20. Lagrand W.K., Visser C.A., Hermens W.T., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999) 96-102
21. Calabro P., Willerson J.T., and Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 (2003) 1930-1932
22. Zairis M.N., Lyras A.G., Bibis G.P., et al. Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction. Atherosclerosis 182 (2005) 161-167
23. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. New Engl J Med 347 (2002) 5-12
24. Rioufol G., Finet G., Ginon I., et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106 (2002) 804-808
25. Biasucci L.M. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation 110 (2004) e560-e567